Gamston Courtney E, Westrick Salisa C, Zmajevac Mafe, Qian Jingjing, Peden Greg, Hagan Dillon, Lloyd Kimberly Braxton
Harrison College of Pharmacy, Auburn University, Auburn, AL 36849, USA.
Intermountain Health, Grand Junction, CO 81501, USA.
Pharmacy (Basel). 2025 Jul 23;13(4):99. doi: 10.3390/pharmacy13040099.
Pharmacist-led transitions of care (TOC) services decrease preventable hospital readmission. TOC service implementation assessment can inform translation to real-world settings. The purpose of this study was to evaluate the implementation of a TOC service for patients with multiple admissions at a regional hospital using the RE-AIM framework. In this quasi-experimental, non-randomized study, individuals with ≥2 recent hospitalizations received pharmacist-led discharge medication reconciliation and counseling, management of drug-related problems, post-discharge telephonic visits, and social support. The reach, effectiveness, implementation, and maintenance RE-AIM dimensions were assessed using patient and service records. Outcomes included 30-day readmission rates for individuals completing ≥1 outpatient pharmacist visit (intervention) versus those unreachable in the outpatient setting (comparison), completed interventions, implementation features, and service adaptations. Chi-square and Fisher's exact tests were used for comparison of categorical variables and the t-test was used for continuous variables. From February 2022 to August 2023, 72.7% of the 66 service participants participated in the intervention (reach). Additionally, 30-day readmission was 22.9% (intervention) versus 55.6% (comparison; = 0.01). In total, 2279 interventions were documented (effectiveness). The service was adapted (implementation) and expanded to include additional populations (maintenance) to enhance sustainability. Based on RE-AIM evaluation, the pharmacist-led TOC intervention appears to be a sustainable solution for addressing readmission in multivisit patients.
由药剂师主导的护理过渡(TOC)服务可降低可预防的医院再入院率。TOC服务实施评估可为向实际应用场景的转化提供参考。本研究的目的是使用RE-AIM框架评估一家地区医院为多次入院患者提供的TOC服务的实施情况。在这项准实验性、非随机研究中,近期住院≥2次的个体接受了由药剂师主导的出院用药核对与咨询、药物相关问题管理、出院后电话随访以及社会支持。使用患者和服务记录评估RE-AIM的覆盖范围、有效性、实施情况和维持情况等维度。结果包括完成≥1次门诊药剂师访视的个体(干预组)与门诊环境中无法联系到的个体(对照组)的30天再入院率、完成的干预措施、实施特征和服务调整。卡方检验和Fisher精确检验用于分类变量的比较,t检验用于连续变量的比较。2022年2月至2023年8月,66名服务参与者中有72.7%参与了干预(覆盖范围)。此外,30天再入院率在干预组为22.9%,在对照组为55.6%(P = 0.01)。总共记录了2279项干预措施(有效性)。该服务进行了调整(实施情况)并扩大到包括更多人群(维持情况)以提高可持续性。基于RE-AIM评估,由药剂师主导的TOC干预似乎是解决多次就诊患者再入院问题的可持续解决方案。